CytoVive PRP -Platelet-Rich Plasma Kits for Autologous Therapy

CytoVive specializes in providing advanced FDA-approved Class 2 medical devices under the brands Tropocells and Cellenis, designed for the efficient preparation of autologous Platelet-Rich Plasma (PRP) at the point of care. These PRP kits, intended for single use, leverage proprietary thixotropic gel separator technology. This innovative technology facilitates the extraction of intact platelets, while filtering out proinflammatory cytokines, ensuring high-quality PRP preparations. Key features include a closed system design and a simple three-step protocol that completes in a single five-minute centrifugation spin cycle. The kits allow clinicians to adjust PRP concentrations according to specific clinical needs, supporting a range of regenerative applications. With leukocyte-neutral, natural and exogenously activated PRP options, these kits cater to diverse clinical indications and procedures. Clinicians can confidently use these devices to support effective healing processes, owing to their robust scientific backing and flexible application potentials.